The flagship engagement
The Post-Sale Operating Blueprint
When companies reach out
Symptoms that commonly trigger this engagement
- Gross or net revenue retention has declined or stalled below plan
- A Customer Success or CX leader recently left, and the gap has become a forcing function
- A new CS or CX leader wants an independent baseline before committing to a plan
- Leadership is about to approve a CS platform purchase and wants a sanity check first
- The board is asking retention questions the executive team can't answer with confidence
- CSM headcount requests keep coming, but nobody can say whether more people is the fix
- A reorganization is being discussed, and leadership wants it grounded in evidence, not instinct
Why this keeps happening
Why companies misdiagnose retention problems
The team closest to the symptom investigates it
CS leaders are asked to diagnose retention problems that may originate in sales, product, or onboarding - functions they don't own and can't objectively assess.
Lagging metrics get mistaken for root causes
GRR and NRR tell you something is wrong months after the decisions that caused it were made. Treating the metric itself as the diagnosis skips the actual investigation.
Anecdote fills the gap where data should be
Without structured interviews and account-level analysis, the loudest or most recent churn story tends to define the whole narrative.
Solutions get chosen before causes are confirmed
"Buy a platform" and "hire more CSMs" are both legitimate answers to some problems and expensive mistakes in response to others. The order matters.
What gets reviewed
Evidence reviewed
- Customer-level retention, renewal, and churn data, segmented by cohort and account type
- CRM and CS platform data on lifecycle stage, health scores, and account ownership
- Onboarding and time-to-value timelines for recent cohorts
- Support ticket volume, escalation patterns, and resolution timelines
- CSM account load and capacity relative to account complexity
- Sales process artifacts: ICP definitions, discovery notes, and deal terms where available
- Existing reporting, dashboards, and QBR materials
Who's involved
Stakeholders interviewed
- CEO, COO, or the executive sponsor of the engagement
- Head or VP of Customer Success (or the role currently covering it)
- Sales or CRO leadership, for handoff and expectation-setting context
- Product or engineering leadership, where product maturity is a live question
- Individual CSMs or account managers doing the day-to-day work
- Support or implementation leadership, where those functions are separate from CS
Full diagnostic scope
Diagnostic categories
Every engagement examines these thirteen areas, though the depth in each varies based on where the early evidence points.
- 01
Customer segmentation and ICP alignment
Whether churning accounts share traits that predict fit problems sales or marketing should address upstream.
- 02
Sales-to-post-sale handoff
What gets communicated, lost, or promised between the close of a deal and the start of onboarding.
- 03
Onboarding and implementation
Whether time-to-first-value is a process problem, a product complexity problem, or a resourcing problem.
- 04
Product adoption
Whether usage patterns show genuine engagement or surface-level activity that predicts future churn.
- 05
Support and escalation patterns
Whether support issues are noise, or a signal of product or implementation gaps being absorbed by CS.
- 06
Renewal ownership and forecasting
Who owns the renewal, how it's forecast, and how early risk is actually identified.
- 07
Expansion responsibilities
Whether expansion is a natural extension of adoption or a separate motion competing for CSM attention.
- 08
Team roles and organizational design
Whether the current structure matches the complexity of the customer base it serves.
- 09
CSM capacity and competing priorities
Whether workload is modeled against account complexity, or assigned by headcount alone.
- 10
Systems, data quality, and reporting
Whether the data needed to run the business actually exists, and whether people trust it.
- 11
AI readiness and automation opportunities
Where automation could remove real manual effort, evaluated against your data maturity, not hype.
- 12
Build-versus-buy considerations
Whether new software would solve the constraint, or whether process and ownership gaps would undermine it.
- 13
Executive alignment and decision rights
Whether leadership agrees on priorities and who has authority to act on the roadmap.
What leadership receives
Deliverables
- Executive diagnosis summarizing the findings in plain, decision-ready language
- Root-cause hypotheses, each supported by the specific evidence behind it
- A customer lifecycle map showing ownership at every stage from sale to renewal
- An ownership and accountability map across sales, CS, support, and product
- A capacity and workload assessment for the post-sale team
- A revenue-at-risk analysis grounded in your account data
- A systems and data architecture review
- A build-versus-buy recommendation where software is a live question
- A prioritized 90-day action plan
- A longer-term operating roadmap sequenced in the right order
- Leading indicators and success measures to track before GRR or NRR move
- An explicit "not now" list of reasonable ideas that aren't the current priority
- Risks, dependencies, and the specific executive decisions required to proceed
What to expect
Timeline
Week 1
Kickoff, data access, and the first round of executive interviews.
Weeks 2-3
Evidence review, additional stakeholder interviews, and cross-functional analysis.
Week 4
Root-cause synthesis and roadmap drafting.
Week 5
Delivery of the executive diagnosis and roadmap, presented to leadership.
Measuring success honestly
Appropriate success measures
This engagement will not promise a specific GRR or NRR increase, and you should be skeptical of anyone who does. Operational improvements are usually visible in weeks; retention metrics take longer because they are lagging indicators tied to your renewal cycle.
30 to 90 days
Operational changes become visible: handoff quality, onboarding cycle time, renewal forecast accuracy, and CSM capacity utilization.
3 to 9 months
Leading customer indicators begin to move: product adoption depth, time-to-value, support escalation rates, and renewal risk flags caught earlier.
12 to 18 months or more
GRR and NRR, which are lagging outcomes, reflect the cumulative effect of the changes. Monthly-contract businesses tend to see this sooner than annual-contract businesses, because the feedback loop is shorter.
These recommendations reduce controllable operational risk. They cannot eliminate product, market, budget, competitive, or customer-specific factors outside the post-sale organization's control.
After the roadmap
What happens after the roadmap is delivered
You execute internally
Many clients take the roadmap and run with it using their own team. The deliverables are built to be actionable without further involvement from this practice.
You bring in Transformation Leadership
If the internal team doesn't have capacity to drive the first 90 days, Transformation Leadership provides dedicated execution support for that window.
You pursue targeted Design work
Some roadmaps point to a specific design gap - organizational structure, capacity modeling, or systems architecture - addressed through a scoped Customer Success Architecture engagement.
You evaluate Fractional CCO leadership
If the roadmap reveals a need for ongoing, accountable post-sale leadership and the company has the alignment for it, that's a separate and more selective conversation.
Is this a fit?
Qualification criteria
- You're a B2B SaaS company, roughly $8M to $75M in ARR, with enough customer and organizational complexity for a post-sale operating problem to exist
- There is an executive sponsor - typically a CEO, COO, CFO, CRO, or CCO - who wants an independent, evidence-based answer
- You're willing to grant access to the data and people needed to do the analysis properly
- You want a diagnosis and roadmap, not a guaranteed number or a pre-decided conclusion
Common questions
FAQ
Will this tell us exactly how much GRR or NRR will improve?
No, and any diagnostic that promises a specific number should be treated skeptically. The engagement quantifies revenue at risk and identifies the operational constraints inside your control. It cannot control for product, market, budget, competitive, or customer-specific factors outside the post-sale organization's authority.
Do we need to have our data in perfect shape before starting?
No. Assessing data quality and gaps is part of the diagnostic itself. Imperfect or fragmented data is a common finding, not a disqualifier.
Will you tell us we need to buy a platform?
Only if the evidence supports it. Build-versus-buy analysis is part of the diagnostic scope, and the honest answer is sometimes 'not yet' or 'fix your process first.'
Who needs to be involved from our side?
An executive sponsor, the CS or CX leader (if one exists), and access to the cross-functional stakeholders listed on this page. Most engagements involve 6 to 10 internal interviews.
What if the diagnosis points to a problem outside Customer Success entirely?
That happens regularly, and it's often the most valuable finding. The roadmap will say so plainly, whether the constraint sits in ICP fit, sales process, product maturity, or somewhere else.
Next step
Discuss whether the Blueprint fits your situation
Bring what you know and what you don't. The first conversation is about fit, not a sales pitch.